Browsing Tag
Lundbeck Pharmaceuticals
1 post
Lupin secures FDA approval to launch generic vigabatrin oral solution in the US market
Lupin secures US FDA approval for generic vigabatrin oral solution, a $275M epilepsy drug, boosting its US generics and neurology portfolio.